Metacrine Inc reports results for the quarter ended in September - Earnings Summary

Metacrine

14/11/2022 23:39

* Metacrine Inc  MTCR.OQ  reported a quarterly adjusted loss
of 13
cents​​ per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 10
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Metacrine Inc's reported EPS for the quarter was a loss
of 13
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Metacrine Inc shares had fallen by 14.1% this quarter and
lost 38.2% so far this year.
    * The company reported a quarterly loss of $5.52 million.
    * Wall Street's median 12-month price target for Metacrine
Inc is
$0.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 11:39 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.10          -0.13          Missed
 Jun. 30 2022      -0.25          -0.15          Beat
 Mar. 31 2022      -0.39          -0.31          Beat
 Dec. 31 2021      -0.63          -0.32          Beat